Primary acute myeloid leukemia cells with IDH1 or IDH2 mutations respond to a DOT1L inhibitor in vitro
7 Kastritis E, Terpos E, Moulopoulos L, Spyropoulou-Vlachou M, Kanellias N, Eleftherakis-
Papaiakovou E et al. Extensive bone marrow infiltration and abnormal free light chain ratio
identifies patients with asymptomatic myeloma at high risk for progression to symptomatic
disease. Leukemia 2013; 27: 947-53. 8 Perez-Persona E, Vidriales MB, Mateo G, Garcia-
Sanz R, Mateos MV, de Coca AG et al. New criteria to identify risk of progression in
monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based …
Papaiakovou E et al. Extensive bone marrow infiltration and abnormal free light chain ratio
identifies patients with asymptomatic myeloma at high risk for progression to symptomatic
disease. Leukemia 2013; 27: 947-53. 8 Perez-Persona E, Vidriales MB, Mateo G, Garcia-
Sanz R, Mateos MV, de Coca AG et al. New criteria to identify risk of progression in
monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based …
7 Kastritis E, Terpos E, Moulopoulos L, Spyropoulou-Vlachou M, Kanellias N, Eleftherakis-Papaiakovou E et al. Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease. Leukemia 2013; 27: 947-53. 8 Perez-Persona E, Vidriales MB, Mateo G, Garcia-Sanz R, Mateos MV, de Coca AG et al. New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells. Blood 2007; 110: 2586-2592.
nature.com